Design of studies to evaluate the safety and efficacy of fish vaccines - Scientific guideline
Human medicines European public assessment report (EPAR): Inluriyo, imlunestrant, Date of authorisation: 09/01/2026, Status: Authorised
User safety for immunological veterinary medicinal products - Scientific guideline
Draft guideline on the requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Revision 1
Requirements for combined vaccines and associations of immunological veterinary medicinal products (IVMPs) - Scientific guideline
Human medicines European public assessment report (EPAR): Steqeyma, ustekinumab, Date of authorisation: 22/08/2024, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Byooviz, ranibizumab, Date of authorisation: 18/08/2021, Revision: 11, Status: Authorised
Scientific advice and protocol assistance adopted during the CHMP meeting 8-11 December 2025
Investigation and assessment of cardiovascular safety of anticancer medicinal products
Reflection paper on investigation and assessment of cardiovascular safety of anticancer medicinal products